Literature DB >> 17395340

Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients.

Sima Rafati1, Elham Gholami, Nafiseh Hassani, Fatemeh Ghaemimanesh, Yasaman Taslimi, Tahereh Taheri, Lynn Soong.   

Abstract

Heat shock proteins (HSP) are highly conserved molecules that play important roles in protein folding, assembly of protein complexes and translocation of proteins across cellular compartments, as well as in several immunological processes. In this study, we first immunized susceptible BALB/c and resistant C57BL/6 mice with the complete open-reading frame of Leishmania HSP-70 (pcDNA-HSP70) and boosted mice with rHSP-70 (amino acid 221-604 cloned in pQE-HSP70 and referred to as rHSP70) mixed with Montanide 720. When we evaluated the effects of HSP70 in both mouse strains, we found that the entire fragment (amino acids 221-604) and rCT-HSP70 (amino acids 491-604 cloned in pQE-CT), but not rNT-HSP70 (amino acids 221-291 cloned pQE-NT), contained the highest immunogenicity. However, after infectious challenge with Leishmania major, no efficient protective responses were observed in either mouse strain. The humoral immune responses against the different truncated forms of HSP70 suggested a mixed TH1/TH2 response in vivo. We then assessed infected susceptible and resistant mice for lymphoproliferative and cytokine responses against the truncated forms of HSP70. At 9-week post-infection, we observed no differences in those responses between vaccinated and control mice. Next, we initiated comparative studies in human patient samples, finding no significant proliferation against all three truncated forms of HSP70 in the cellular immune responses of 16 cured cutaneous leishmaniasis patients and 5 normal individuals. Sera from active cutaneous and visceral leishmaniasis patients, however, were reactive to all three forms of HSP70. This study demonstrates the potential of HSP70 in stimulating humoral responses in humans and mice and indicates there is a need to further explore and examine the value of this important molecule in the control of leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395340     DOI: 10.1016/j.vaccine.2007.03.006

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  20 in total

1.  Identification and characterization of a novel Leishmania donovani antigen for serodiagnosis of visceral leishmaniasis.

Authors:  Subodh Kumar; Dinesh Kumar; Jaya Chakravarty; Madhukar Rai; Shyam Sundar
Journal:  Am J Trop Med Hyg       Date:  2012-04       Impact factor: 2.345

Review 2.  The genetics of Leishmania virulence.

Authors:  Eugenia Bifeld; Joachim Clos
Journal:  Med Microbiol Immunol       Date:  2015-06-06       Impact factor: 3.402

3.  Molecular characterization of heat shock protein 70 gene transcripts during Vibrio harveyi infection of humphead snapper, Lutjanus sanguineus.

Authors:  Xinzhong Zhang; Huanying Pang; Zaohe Wu; Jichang Jian
Journal:  Fish Physiol Biochem       Date:  2011-05-11       Impact factor: 2.794

4.  Protective immunity using MPL-A and autoclaved Leishmania donovani as adjuvants along with a cocktail vaccine in murine model of visceral leishmaniasis.

Authors:  Tejinder Kaur; Ankita Thakur; Sukhbir Kaur
Journal:  J Parasit Dis       Date:  2012-09-06

Review 5.  Mini-chaperones: potential immuno-stimulators in vaccine design.

Authors:  Azam Bolhassani; Sima Rafati
Journal:  Hum Vaccin Immunother       Date:  2012-10-29       Impact factor: 3.452

6.  Exosome Secretion by the Parasitic Protozoan Leishmania within the Sand Fly Midgut.

Authors:  Vanessa Diniz Atayde; Hamide Aslan; Shannon Townsend; Kasra Hassani; Shaden Kamhawi; Martin Olivier
Journal:  Cell Rep       Date:  2015-10-22       Impact factor: 9.423

7.  Chimeric protein consisting of 3M2e and HSP as a universal influenza vaccine candidate: from in silico analysis to preliminary evaluation.

Authors:  Behrokh Farahmand; Najmeh Taheri; Hadiseh Shokouhi; Hoorieh Soleimanjahi; Fatemeh Fotouhi
Journal:  Virus Genes       Date:  2018-10-31       Impact factor: 2.332

8.  Heat shock proteins enriched-promastigotes of Leishmania major inducing Th2 immune response in BALB/c mice.

Authors:  Marzieh Holakuyee; Mehdi Mahdavi; Zuhair Mohammad Hassan; Mohsen Abolhassani
Journal:  Iran Biomed J       Date:  2012

9.  Immunodominant antigens of Leishmania chagasi associated with protection against human visceral leishmaniasis.

Authors:  Daniel R Abánades; Leonardo V Arruda; Elaine S Arruda; José Roberto A S Pinto; Mario S Palma; Dorlene Aquino; Arlene J Caldas; Manuel Soto; Aldina Barral; Manoel Barral-Netto
Journal:  PLoS Negl Trop Dis       Date:  2012-06-19

10.  Mitigating an undesirable immune response of inherent susceptibility to cutaneous leishmaniosis in a mouse model: the role of the pathoantigenic HISA70 DNA vaccine.

Authors:  Gustavo Domínguez-Bernal; Pilar Horcajo; José A Orden; Ricardo De La Fuente; Aldara Herrero-Gil; Lara Ordóñez-Gutiérrez; Javier Carrión
Journal:  Vet Res       Date:  2012-08-09       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.